Cargando…

Correlation of CD133 and Oct-4 expression with clinicopathological and demographic parameters in oral squamous cell carcinoma patients

OBJECTIVE: Squamous cell carcinoma of oral cavity is one of the most common cancers of Indian subcontinent with the 5-year survival rate of 50% despite the recent advances in the treatment. The aim of the present study was to study cancer stem cell markers CD133 and Oct-4 in oral squamous cell carci...

Descripción completa

Detalles Bibliográficos
Autores principales:	Singh, Alok, Srivastava, Anand Narain, Akhtar, Salman, Siddiqui, Mohammad Haris, Singh, Pooja, Kumar, Vijay
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2018
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5996651/ https://www.ncbi.nlm.nih.gov/pubmed/29937653 http://dx.doi.org/10.4103/njms.NJMS_60_17

Ejemplares similares

Prognostic utility of microRNA-145 and CD 133 in oral squamous cell carcinoma: A pilot study from Northern India
por: Singh, Alok, et al.
Publicado: (2023)

Circulating MicroRNA-21 Expression as a Novel Serum Biomarker for Oral Sub-Mucous Fibrosis and Oral Squamous Cell Carcinoma
por: Singh, Pooja, et al.
Publicado: (2018)

Expression of HIF-1α, ANXA3, CD133 and their associations with clinicopathological parameters in human colon carcinoma
por: Chai, Xiaoyan, et al.
Publicado: (2022)

Clinicopathological significance of cancer stem cells marked by CD133 and KAI1/CD82 expression in laryngeal squamous cell carcinoma
por: Yu, Lan, et al.
Publicado: (2014)

Clinicopathological significance of CD133 and CD44 expression in infiltrating ductal carcinoma and their relationship to angiogenesis
por: Han, Zhengquan, et al.
Publicado: (2015)

Low Expression of MicroRNA335-5p Is Associated with Malignant Behavior of Gallbladder Cancer: A Clinicopathological Study
por: Fatima, Naseem, et al.
Publicado: (2019)

Significance of CD133 expression in esophageal squamous cell carcinoma
por: Okamoto, Hiroshi, et al.
Publicado: (2013)

SNP rs2240688 in CD133 gene on susceptibility and clinicopathological features of hepatocellular carcinoma
por: Pan, Xiaolan, et al.
Publicado: (2020)

Oct-4: a prognostic biomarker of urinary bladder cancer in North India
por: Siddiqui, Zainab, et al.
Publicado: (2019)

Clinicopathological Analysis and Demographic Features of Ocular Malignancies
por: Al-Mujaini, Abdullah, et al.
Publicado: (2021)

Prognostic Impact and Clinicopathological Correlation of CD133 and ALDH1 Expression in Invasive Breast Cancer
por: Kim, Sung Jeep, et al.
Publicado: (2015)

Clinicopathological Significance of Tumor Stem Cell Markers ALDH1 and CD133 in Colorectal Carcinoma
por: Rezaee, Maryam, et al.
Publicado: (2021)

Oct-4 Expression Maintained Cancer Stem-Like Properties in Lung Cancer-Derived CD133-Positive Cells
por: Chen, Yu-Chih, et al.
Publicado: (2008)

Comments on the "Prognostic Impact and Clinicopathological Correlation of CD133 and ALDH1 Expression in Invasive Breast Cancer"
por: Ieni, Antonio, et al.
Publicado: (2016)

Assessment of immunohistochemical expression of p16 in head and neck squamous cell carcinoma and their correlation with clinicopathological parameters
por: Pandey, Pinki, et al.
Publicado: (2021)

Oxytetracycline have the therapeutic efficiency in CD133(+) HCC population through suppression CD133 expression by decreasing of protein stability of CD133
por: Song, Yeonhwa, et al.
Publicado: (2018)

Study the Expression of CD10 in Prostate Carcinoma and its Correlation with Various Clinicopathological Parameters
por: Singh, Lalit, et al.
Publicado: (2019)

Expression of CD133 and CD24 and their different phenotypes in urinary bladder carcinoma
por: Farid, Rola M, et al.
Publicado: (2019)

The Clinicopathological Significance of miR-133a in Colorectal Cancer
por: Wan, Timothy Ming-Hun, et al.
Publicado: (2014)

Role of CD133(+) cells in tongue squamous carcinomas: Characteristics of ‘stemness’ in vivo and in vitro
por: Wang, Kai, et al.
Publicado: (2016)

Does Harvey-Ras gene expression lead to oral squamous cell carcinoma? A clinicopathological aspect
por: Krishna, Akhilesh, et al.
Publicado: (2018)

Immunoexpression of Tumor Infiltrating Lymphocytes(TILS) CD4 + and CD8 + in Oral Squamous Cell Carcinoma (OSCC) in Correlations with Clinicopathological Characteristics and Prognosis
por: Wahbi, Hanan Salman, et al.
Publicado: (2022)

Epigenetic regulation of CD133 and tumorigenicity of CD133 positive and negative endometrial cancer cells
por: Friel, Anne M, et al.
Publicado: (2010)

Iterative sorting reveals CD133+ and CD133- melanoma cells as phenotypically distinct populations
por: Grasso, Carole, et al.
Publicado: (2016)

FNAB of metastatic lesions with special reference to clinicopathological analysis of primary site in cases of epithelial and non-epithelial tumors
por: Ahmad, Shamshad, et al.
Publicado: (2011)

Association of E-cadherin & vimentin expression with clinicopathological parameters in lingual squamous cell carcinomas & their role in incomplete epithelial mesenchymal transition
por: Goyal, Neelakshi, et al.
Publicado: (2021)

Clinicopathologic Significance of Survivin Expression in Relation to CD133 Expression in Surgically Resected Stage II or III Colorectal Cancer
por: Li, Wanlu, et al.
Publicado: (2017)

Clinicopathological characteristics and prognostic value of cancer stem cell marker CD133 in breast cancer: a meta-analysis
por: Li, Zhan, et al.
Publicado: (2017)

The Clinicopathological Profile of Eosinophilic Myocarditis
por: Sheikh, Haris, et al.
Publicado: (2018)

CD133 Expression and Identification of CD133/nestin Positive Cells in Rhabdomyosarcomas and Rhabdomyosarcoma Cell Lines
por: Sana, Jiri, et al.
Publicado: (2011)

Differential number of CD34+, CD133+ and CD34+/CD133+ cells in peripheral blood of patients with congestive heart failure
por: Fritzenwanger, M, et al.
Publicado: (2009)

Combined prognostic value of the cancer stem cell markers CD47 and CD133 in esophageal squamous cell carcinoma
por: Wang, Jian‐Hua, et al.
Publicado: (2019)

In triple negative breast tumor cells, PLC-β2 promotes the conversion of CD133(high) to CD133(low) phenotype and reduces the CD133-related invasiveness
por: Brugnoli, Federica, et al.
Publicado: (2013)

CD133 Role in Oral Carcinogenesis
por: Luna, Ealber Carvalho Macedo, et al.
Publicado: (2020)

CD133 expression correlates with clinicopathologic features and poor prognosis of colorectal cancer patients: An updated meta-analysis of 37 studies
por: Huang, Rongyong, et al.
Publicado: (2018)

Expressions and clinical significances of CD133 protein and CD133 mRNA in primary lesion of gastric adenocacinoma
por: Yu, Ji-wei, et al.
Publicado: (2010)

Clinicopathological Parameters Predicting Nodal Metastasis in Head and Neck Squamous Cell Carcinoma
por: Hashmi, Atif A, et al.
Publicado: (2023)

CD133 overexpression correlates with clinicopathological features of gastric cancer patients and its impact on survival: A systematic review and meta-analysis
por: Yiming, Li, et al.
Publicado: (2015)

CD133 expression correlates with clinicopathologic features and poor prognosis of colorectal cancer patients: An updated meta-analysis of 37 studies: Erratum
Publicado: (2018)

Estimation of serum β2-microglobulin in potentially malignant disorders and squamous cell carcinoma of the oral cavity: A clinicopathological study
por: Singh, Anand Pratap, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_433ie5v9kg6hqrh6e0tnsoq10k